晚期卵巢癌联合手术的直接效果:俄罗斯卫生部N. N. Blokhin国家肿瘤医学研究中心的经验

O. Kozhevnikova, S. A. Nikogosyan, V. S. Ananyev, V. V. Kyznetsov, A. S. Shevchuk
{"title":"晚期卵巢癌联合手术的直接效果:俄罗斯卫生部N. N. Blokhin国家肿瘤医学研究中心的经验","authors":"O. Kozhevnikova, S. A. Nikogosyan, V. S. Ananyev, V. V. Kyznetsov, A. S. Shevchuk","doi":"10.17650/2686-9594-2019-9-4-32-36","DOIUrl":null,"url":null,"abstract":"Objective: to analyze intraoperative and postoperative complications in patients who underwent combination surgeries for advanced ovarian cancer. Materials and methods . This retrospective study included patients that underwent primary or interval cytoreductive combination surgeries for advanced (grade III–IV) ovarian cancer at N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia between 2000 and 2017. Results . We analyzed medical records of 144 patients with grade III–IV ovarian cancer who underwent combination surgery at some stage of their treatment. Almost two-thirds of patients (64.8 %) had complete or optimal volume of surgery. Intraoperative complications were registered in 7 % of patients (n = 10), while postoperative complications were observed in 38.2 % of cases (n = 55). The postoperative death rate was 0.7 % (n = 1). Conclusions . Higher frequency of complete and optimal cytoreduction, as well as acceptable level of intra- and postoperative complications confirm the need for combination surgeries in patients with advanced ovarian cancer. Aggressive surgical tactics should be used only in specialized cancer hospitals with the involvement of a multidisciplinary team that includes cancer surgeons and anesthesiologists in order to improve both short-term and long-term treatment outcomes in patients with advanced ovarian cancer.","PeriodicalId":34449,"journal":{"name":"Tazovaia khirurgiia i onkologiia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The immediate results of combined operations in patients with advanced ovarian cancer: the experience of N. N. Blokhin National Medical research Center of Oncology, Ministry of health of russia\",\"authors\":\"O. Kozhevnikova, S. A. Nikogosyan, V. S. Ananyev, V. V. Kyznetsov, A. S. Shevchuk\",\"doi\":\"10.17650/2686-9594-2019-9-4-32-36\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: to analyze intraoperative and postoperative complications in patients who underwent combination surgeries for advanced ovarian cancer. Materials and methods . This retrospective study included patients that underwent primary or interval cytoreductive combination surgeries for advanced (grade III–IV) ovarian cancer at N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia between 2000 and 2017. Results . We analyzed medical records of 144 patients with grade III–IV ovarian cancer who underwent combination surgery at some stage of their treatment. Almost two-thirds of patients (64.8 %) had complete or optimal volume of surgery. Intraoperative complications were registered in 7 % of patients (n = 10), while postoperative complications were observed in 38.2 % of cases (n = 55). The postoperative death rate was 0.7 % (n = 1). Conclusions . Higher frequency of complete and optimal cytoreduction, as well as acceptable level of intra- and postoperative complications confirm the need for combination surgeries in patients with advanced ovarian cancer. Aggressive surgical tactics should be used only in specialized cancer hospitals with the involvement of a multidisciplinary team that includes cancer surgeons and anesthesiologists in order to improve both short-term and long-term treatment outcomes in patients with advanced ovarian cancer.\",\"PeriodicalId\":34449,\"journal\":{\"name\":\"Tazovaia khirurgiia i onkologiia\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tazovaia khirurgiia i onkologiia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/2686-9594-2019-9-4-32-36\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tazovaia khirurgiia i onkologiia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2686-9594-2019-9-4-32-36","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:分析晚期卵巢癌联合手术的术中、术后并发症。材料和方法。本回顾性研究纳入了2000年至2017年期间在俄罗斯卫生部N. N. Blokhin国家肿瘤医学研究中心接受原发性或间隔期细胞减少联合手术治疗晚期(III-IV级)卵巢癌的患者。我们分析了144例III-IV级卵巢癌患者的医疗记录,这些患者在治疗的某个阶段接受了联合手术。几乎三分之二的患者(64.8%)完成了手术或最佳手术量。术中并发症发生率为7% (n = 10),术后并发症发生率为38.2% (n = 55)。术后死亡率为0.7% (n = 1)。更高频率的完全和最佳细胞减少,以及可接受的手术内和术后并发症,证实了晚期卵巢癌患者联合手术的必要性。为了改善晚期卵巢癌患者的短期和长期治疗效果,积极的手术策略应该只在专门的癌症医院使用,并有包括癌症外科医生和麻醉师在内的多学科团队的参与。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The immediate results of combined operations in patients with advanced ovarian cancer: the experience of N. N. Blokhin National Medical research Center of Oncology, Ministry of health of russia
Objective: to analyze intraoperative and postoperative complications in patients who underwent combination surgeries for advanced ovarian cancer. Materials and methods . This retrospective study included patients that underwent primary or interval cytoreductive combination surgeries for advanced (grade III–IV) ovarian cancer at N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia between 2000 and 2017. Results . We analyzed medical records of 144 patients with grade III–IV ovarian cancer who underwent combination surgery at some stage of their treatment. Almost two-thirds of patients (64.8 %) had complete or optimal volume of surgery. Intraoperative complications were registered in 7 % of patients (n = 10), while postoperative complications were observed in 38.2 % of cases (n = 55). The postoperative death rate was 0.7 % (n = 1). Conclusions . Higher frequency of complete and optimal cytoreduction, as well as acceptable level of intra- and postoperative complications confirm the need for combination surgeries in patients with advanced ovarian cancer. Aggressive surgical tactics should be used only in specialized cancer hospitals with the involvement of a multidisciplinary team that includes cancer surgeons and anesthesiologists in order to improve both short-term and long-term treatment outcomes in patients with advanced ovarian cancer.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
25
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信